Results 241 to 250 of about 8,736,512 (307)

Strategies to Increase Response Rate and Reduce Nonresponse Bias in Population Health Research: Analysis of a Series of Randomized Controlled Experiments during a Large COVID-19 Study.

JMIR Public Health Surveill
Atchison CJ, Gilby N, Pantelidou G, Clemens S, Pickering K, Chadeau-Hyam M, Ashby D, Barclay WS, Cooke GS, Darzi A, Riley S, Donnelly CA, Ward H, Elliott P.   +13 more
europepmc   +1 more source

Quantitative proteomic analysis reveals different characteristics of bladder cancer cells after exposure to bisphenol A

FEBS Open Bio, EarlyView.
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu, Lanlan Li, Wenjuan Jia, Hanzhong Feng, Xiaoquan Yu, Youli Zhao, Fengzhi Yuan, Hui Ding, Junqiang Tian, Yong‐Xing He, Zhiping Wang   +10 more
wiley   +1 more source

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy. [PDF]

Diagn Pathol
Dou H, Li F, Wang Y, Chen X, Yu P, Jia S, Ba Y, Luo D, Gao T, Li Z, Xiao M.   +10 more
europepmc   +1 more source

Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2-positive early breast cancer: A meta-regression analysis. [PDF]

Cancer Med
Yang MH, Huang CS, Chang DY, Hu FC, Huang SM, Huang PH, Chen IC, Chen TW, Lin CH, Lu YS.   +9 more
europepmc   +1 more source

Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. [PDF]

J Immunother Cancer
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Response rates ? an evolution

Cancer Chemotherapy and Pharmacology, 1994
The documented frequency of response of cancers to common chemotherapy agents and combinations appears to have decreased over the decades. Multiple reasons exist for this decline including: changes in eligibility and evaluability criteria; changes in the type of patients entered onto trial; and, altered criteria for response and methods for response ...
E, Poplin, L, Baker
openaire   +2 more sources

Surveys and Response Rates

Pediatrics In Review, 2015
Surveys continue to be an important research methodology. However, when assessing survey studies, clinicians should review the response rate and consider potential selection bias. Methods of survey administration (electronic, postal, or other means) may differ in cost, missing data, and response rates.
David M, Berman, Litjen L J, Tan, Tina L, Cheng   +2 more
openaire   +2 more sources

Rate‐Drop Response Programming

Pacing and Clinical Electrophysiology, 1997
Effective programming of the rate‐drop response algorithm requires careful attention to the heart rate and blood pressure responses seen during diagnostic tilt testing. In order to undertake effective programming, additional tilt testing procedures may be necessary, and it is vital that the protocol should be identical on each occasion and very careful
openaire   +2 more sources